Earth Corporation
Financial Summary for the Second Quarter of the Fiscal Year Ending December 2026
Sales are on a steady path with growth targets both domestically and internationally. The earnings material shows trends in revenue, operating income, ordinary income, net income, by segment trends, cost structure changes, and potential revisions to the outlook for the period.
Key Figures
- Revenue: 1,090 hundred million yen (vs. plan +0.1%)
- Gross profit: 472.3 hundred million yen
- SG&A: 340.1 hundred million yen
- Operating income: 132.1 hundred million yen
- Ordinary income: 134.8 hundred million yen
AI要約
Section heading
Key highlights show the current status of revenue and various profit indicators, year-over-year trends, regional and product mix movements, changes in cost structure, and potential revisions to the outlook.
Second section heading
Future growth measures include expanding domestic and international markets, strengthening product lines, optimizing promotional expenses, and improving operational efficiency, with emphasis on manufacturing and operations optimization.
Revenue Trend
Operating Income Trend
Projection vs Actual
Earth Pharmaceutical Co., Ltd.
Company overview · Stock price · Financial data · All IR
